Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.
Journal: Research square
Published: March 27, 2026
Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.
Journal: Research square
Published: March 27, 2026
Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.
Journal: Nature communications
Published: March 11, 2026
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 23, 2025
Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 21, 2025
AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 18, 2025
IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathology.
Journal: Brain : a journal of neurology
Published: January 21, 2025
Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures.
Journal: Cell
Published: September 15, 2024
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy.
Journal: Journal of neuroimmunology
Published: June 17, 2024
Remission of severe myasthenia gravis after autologous stem cell transplantation.
Journal: Annals of clinical and translational neurology
Published: June 07, 2023
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis.
Journal: Annals of clinical and translational neurology
Published: January 26, 2023
Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology.
Journal: Acta neuropathologica
Published: January 05, 2023
Last Updated: 09/26/2026